Gennex Laboratories Ltd

Healthcare · Pharmaceuticals & Biotechnology

BSE: 531739

₹9.95

Sept. 30, 2026 · BSE · bse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #113 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Gennex Laboratories Ltd (this stock)	242	15.1	7.4%	-37.9%	—	58	89	45

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹265 Cr

EV / EBITDA

12.6x

EV / Sales

2.05x

Market cap / Sales

1.88x

Earnings yield

6.63%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 37 Cr, up 31.4% YoY.

↓ Negative

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 4 Cr, down 4.7% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	35	4	4	₹0.1600
March 31, 2026	37	3	3	₹0.1300
Dec. 31, 2025	28	5	4	₹0.1800
Sept. 30, 2025	29	5	5	₹0.1900
June 30, 2025	26	5	4	₹0.1800
Dec. 31, 2024	25	5	4	₹0.1850
Sept. 30, 2024	25	5	4	₹0.1830
June 30, 2024	21	5	4	₹0.1830
March 31, 2024	21	5	4	₹0.2370
Dec. 31, 2023	17	3	3	₹0.1490
Sept. 30, 2023	14	4	3	₹0.1500
June 30, 2023	14	3	3	₹0.1460
March 31, 2023	18	2	2	₹0.0960

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	37	38	31	31	28	27	27	24	23	19	14	14	20
Operating revenue	35	37	28	29	26	25	25	21	21	17	14	14	18
Other income	2	1	3	2	2	2	2	2	2	2	0	0	2
Operating expenses	32	34	25	25	22	22	21	18	18	16	10	10	17
Operating profit	3	3	4	4	3	3	4	3	3	1	4	4	1
Operating profit margin	8.5%	7.9%	12.8%	13.5%	13.2%	13.8%	15.0%	13.7%	14.5%	8.4%	27.9%	27.7%	7.0%
Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest	1	1	1	1	1	0	0	0	0	0	0	0	1
Exceptional items, gain / (loss)	—	—	-0	—	—	—	—	—	—	—	—	—	—
Profit before tax	4	3	5	5	5	5	5	5	5	3	4	3	2
Tax	0	0	0	1	1	1	1	1	1	1	1	1	0
Net profit	4	3	4	5	4	4	4	4	4	3	3	3	2
EPS	0.16	0.13	0.18	0.19	0.18	0.19	0.18	0.18	0.24	0.15	0.15	0.15	0.10
Net profit (TTM)	16	16	17	17	17	16	15	13	12	10	8	6	5
EPS (TTM)	0.66	0.68	0.74	0.74	0.73	0.79	0.75	0.72	0.68	0.54	0.46	0.39	0.31

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	23.2%	16.3%	128^†	71^†	69^†	63^†	60^†	57^†	57^†	47^†	42^†
Operating revenue	22.6%	15.0%	120^†	67^†	65^†	61^†	60^†	56^†	56^†	47^†	42^†
Other income	—	—	8^†	4^†	3^†	1^†	1^†	1^†	1^†	1^†	0^†
Operating expenses	—	—	106^†	54^†	61^†	56^†	53^†	—	52^†	—	37^†
Operating profit	44.5%	16.2%	14^†	12^†	5^†	5^†	7^†	—	4^†	—	5^†
Operating profit margin	—	—	11.5%^†	18.6%^†	7.0%^†	8.8%^†	11.0%^†	—	7.2%^†	—	11.8%^†
Depreciation	—	—	1^†	1^†	1^†	1^†	1^†	—	1^†	1^†	1^†
Interest	—	—	2^†	1^†	1^†	1^†	1^†	1^†	1^†	—	1^†
Exceptional items, gain / (loss)	—	—	-0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	44.8%	27.4%	18^†	15^†	6^†	5^†	5^†	3^†	3^†	1^†	3^†
Tax	—	—	2^†	3^†	1^†	1^†	1^†	1^†	—	—	0^†
Net profit	52.4%	29.6%	16^†	12^†	5^†	4^†	4^†	2^†	2^†	1^†	3^†
EPS	30.5%	14.3%	0.68^†	0.68^†	0.31^†	0.33^†	0.35^†	0.71^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	11.5%^†	18.6%^†	7.0%^†	8.8%^†	11.0%^†	—	7.2%^†	—	11.8%^†
EBIT margin	17.3%^†	23.8%^†	11.3%^†	9.8%^†	10.4%^†	5.9%^†	6.8%^†	—	9.1%^†
PBT margin	15.2%^†	22.1%^†	9.2%^†	8.3%^†	9.1%^†	4.6%^†	5.4%^†	3.1%^†	7.4%^†
Net margin	13.5%^†	17.7%^†	7.0%^†	6.4%^†	7.4%^†	3.3%^†	4.0%^†	1.8%^†	6.5%^†
Interest coverage	8.39x^†	13.77x^†	5.57x^†	6.81x^†	8.31x^†	4.50x^†	4.81x^†	—	5.39x^†
Dividend payout	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—
Current ratio	4.57x	—	—	—	—	—	—	—	—
Quick ratio	3.77x	—	—	—	—	—	—	—	—
Debt to equity	0.10x	—	—	—	—	—	—	—	—
Return on equity	7.4%^†	—	—	—	—	—	—	—	—
Return on assets	5.9%^†	—	—	—	—	—	—	—	—
Return on capital employed	9.3%^†	—	—	—	—	—	—	—	—
Asset turnover	0.44x^†	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	-64	-5	65	12	-76
March 31, 2025	-10	3	2	6	-16

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	274	218	194	23	0	238	52	0	22	42
March 31, 2025	218	185	162	1	0	187	29	1	20	25

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.